The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis
Gynecol Endocrinol. 2021 Jan 29;1-6. doi: 10.1080/09513590.2021.1878138
Abolfazl Mehdizadehkashi 1, Samaneh Rokhgireh 1, Kobra Tahermanesh 1, Neda Eslahi 1, Sara Minaeian 2, Mansooreh Samimi 1
Women category starts with the following
- Vitamin D is indispensable for the health of women - editorial June 2022
- ALL of the top 10 health problems of women are associated with low vitamin D
- Overview Women and Vitamin D
- Pregnancy category listing has
947 items along with related searches - Vitamin D is needed before, during and after Pregnancy – May 2022
- Pretern Birth - 95 items as of Dec 2022
- Cancer - Breast category listing has
264 items along with related searches - Fertility and sperm category listing has
150 items along with related searches - Cancer - Ovarian category listing has
26 items along with related searches - Calcium and Vitamin D category listing has
234 items along with related searches - Excessive Calcium supplementation is very bad for the body, and not needed by your bones
- Search for HRT OR "hormone replacement therapy" 301 items as of Jan 2019
- Poor menstrual cycles 2X more likely if poor vitamin D levels - many studies
- Fertility problem (PCOS) reduced by vitamin D, etc. - many studies
- Yeast Infection (Candida etc.) and Vitamin D - many studies
- Bacterial vaginosis reduced 10 times by 2,000 IU of vitamin D – RCT June 2015
- Recurrent urinary tract infection 4X more likely if low vitamin D – Aug 2013
- Endometriosis treated, and perhaps prevented, by vitamin D - many studies
- Infant-Child category listing has
877 items along with related searches Background: To our knowledge, data on the effects of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis are limited. This study was conducted to determine the effects of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis.
Methods: The current randomized, double-blind, placebo-controlled trial was conducted among 60 patients (aged 18-40 years old) with endometriosis. Participants were randomly allocated into two groups (30 participants each group) to receive either 50,000 IU vitamin D or placebo each 2 weeks for 12 weeks.
Results: Vitamin D supplementation significantly decreased
- pelvic pain (β - 1.12; 95% CI, -2.1, -0.09; p=.03) and
- total-/HDL-cholesterol ratio (β - 0.29; 95% CI, -0.57, -0.008; p=.04)
- compared with the placebo.
Moreover, vitamin D intake led to a
- significant reduction in high-sensitivity C-reactive protein (hs-CRP) (β - 0.64 mg/L; 95% CI, -0.97, -0.30; p<.001) and a
- significant increase in total antioxidant capacity (TAC) (β 47.54 mmol/L; 95% CI, 19.98, 75.11; p=.001)
- compared with the placebo.
Conclusions: Overall, our study demonstrated that vitamin D intake in patients with endometriosis resulted in a significant improvement of pelvic pain, total-/HDL-cholesterol ratio, hs-CRP and TAC levels, but did not affect other clinical symptoms and metabolic profiles.
Endometriosis treated by Vitamin D (50,000 IU bi-weekly) – RCT Jan 2021(Cached) Printer Friendly Follow this page for updates4571 visitors, last modified 30 Jan, 2021, This page is in the following categories (# of items in each category)